Rob Goodwin

Rob Goodwin previously served as Senior Vice President of Clinical Development and Operations at Pfizer, where he oversaw global execution of clinical programs as well as some of the core groups to enable clinical trials, with a focus on optimizing trial delivery and operational scalability.

From 2010 to 2015, Mr. Goodwin served as Vice President of Safety Evaluation and Reporting in Pfizer’s Worldwide Safety and Regulatory division. In this role, Mr. Goodwin managed global functions including case processing, medical review, aggregate safety reporting, and regulatory medical writing across local and global markets.

Previously, from 2005 to 2010, Mr. Goodwin held the position of Vice President and Worldwide Head of Global Clinical Data Services, where he was responsible for clinical data management and operations within Development Operations.
 

Mr. Goodwin holds an MBA from Fairleigh Dickinson University’s Silberman College of Business, a master’s degree in research measurement and quantitative analysis from Southern Connecticut State University, and a bachelor’s degree in psychology and business from Eastern Connecticut State University.